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WE attempted to establish an enzyme-linked
immunosorbent assay (ELISA) system by prepara-
tion of recombinant murine MIP-2 and its rabbit
antibodies. A fusion construct of MIP-2 to protein
A was used to enable easy purification as well as
the generation of a sufficiently large antibody
response. The specificity of antibody was con-
firmed by Western blotting analysis of 20-h con-
ditioned medium from lipopolysaccharide (LPS)-
stimulated RAW264.7 cells, a murine macrophage
cell line; antibody gave a single band with a
molecular weight of approximately 6 000, which
is identical to that of murine MIP-2 reported pre-
viously. Biotin-streptavidin sandwich ELISA
could detect quantitatively MIP-2 at concentration
range of 20 to 1 000 pg/ml. In some applications
of this ELISA system, time-related production of
MIP-2 and inhibitory effect of dexamethasone on
its production have been demonstrated in LPS-
stimulated RAW264.7 cells. Thus, ELISA system
established in this study is considered to be a
useful tool to study MIP-2 response in various
inflammation models in mice.
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Introduction
Neutrophil accumulation is an important char-
acteristic of inflammation and modulates various
inflammatory reactions. Recently, novel neu-
trophil chemotactic cytokines (chemokines),
have been found in the conditioned medium
(CM) of various cells including monocytes/mac-
rophages, fibroblasts, endothelial cells and epi-
thelial cells in response to the stimulation with
lipopolysaccharide (LPS) as well as several
inflammatory cytokines such as IL-1 and tumour
necrosis factor.2-7 Several studies on the patho-
genesis of inflammatory diseases have suggested
that chemokine production is the main cause of
the local accumulation of neutrophils and also
their activation.8’9 cDNA of murine macrophage
inflammatory protein 2 (MIP-2), a potent chemo-
tactic agent, has been cloned from murine mac-
rophage RAW 264.7 cells1’11 and MIP-2 is
considered to be a murine counterpart of che-
mokine superfamily based on the closest homo-
logy of cDNA.
2 Although Greenberger et al.13
have touched upon a murine model of bacteria
infection, MIP-2 response to various inflammatory
stimuli has not been studied in detail because of
the difficulty of development of the assay system.
Thus, we attempted to establish an enzyme-
linked immunosorbent assay (ELISA) system for
murine MIP-2, and based on the development of
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the assay system, we applied this ELISA to
examine the time-related MIP-2 production and
inhibitory effect of dexamethasone (DX) in LPS-
stimulated RAW264.7 cells.
Materials and Methods
RAW 264.7 cells, used throughout this study,
were obtained from American Type Culture Col-
lection and cultured in Dulbecco’s modified
Eagle’s minimal essential medium (DMEM). MIP-
2 cDNA was amplified under reverse tran-
scriptase-polymerase chain reaction in the reac-
tion mixture containing purified mRNA from
RAW264.7 cells, which were cultured in the pres-
ence of 1 btg/ml of LPS of Escherichia coli
(O127:B8, Difco, Detroit, MI) for 20h at 37C,
and primers matching to amplify the whole
length of MIP-2 mRNA (221 bases from alanine-
to asparagine-encoding regions).’ Murine MIP-
2 was expressed as a fusion protein with staphy-
lococcal protein A by inserting cDNA of MIP-2
into HindlII and SmaI cutting sites of plasmid
vector pRIT12.12 The construct was confirmed by
sequencing. All recombinant DNA techniques
were performed essentially as described pre-
viously.
2 One of the reasons for the construc-
tion of protein A-MIP-2 expression vector is to
enable easy purification of recombinant MIP-2 by
IgG column. Another reason is that the molecular
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weight (MW) of MIP-2 itself (approximately
6000)1’11 is tOO small tO induce the sufficient
antibody production. Indeed, antibody against
CINC, a rat counterpart of chemokine super-
family, has been prepared by immunization with
keyhole limpets haemocyanine-conjugated ClNC
in the previous study.9
Results and Discussion
When the lysates of E. coli carrying expression
vector were applied to affinity chromatography
on IgG Sepharose GFF column (Pharmacia,
Uppsala, Sweden), the binding fraction on the
column showed a single band with MW of
approximately 50 000 in sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE)
14
(data not shown). This finding indicates that a
single application to the column is sufficient for
the purification of recombinant MIP-2 fused with
protein A of which MW is 42000.15 Thus, the
recombinant MIP-2 was injected intracutaneously
into the rabbit for the preparation of hyper-
immune anti-MIP-2 serum (initially injected with
complete Freund’s adjuvant followed by boosts
with incomplete adjuvant every 2 weeks), and
then anti-MIP-2 IgG was purified using protein G
column (Pharmacia, Uppsala, Sweden). Some
portions of purified anti-MIP-2 IgG were con-
jugated with CNBr-activated Sepharose 6MB
(Pharmacia, Uppsala, Sweden) to examine its
specificity as follows. The lyophilized 20-h CM
from LPS-stimulated RAW264.7 cells was applied
to the anti-MIP-2 IgG-conjugated Sepharose
column, and the binding fraction on the column
was analysed by SDS-PAGE. Alternatively, Western
blotting analyses1 of the CM were carried out.
As shown in Fig. 1, anti-MIP-2 IgG reacted with
single molecule with MW of 6 000, which is iden-
tical to that of murine MIP-2,1’11 in the CM from
LPS-stimulated cells, but not reacted with the CM
from unstimulated cells, confirming the specifi-
city of anti-MIP-2 IgG.
Based on these findings, murine MIP-2 detec-
tion system was prepared as an antibody sand-
wich ELISA in which unlabelled (1.5 gg/ml) and
biotinylated (5 lag/ml) rabbit anti-murine MIP-2
IgG were used as capture and second-layer anti-
bodies, respectively, followed by addition of per-
oxidase-coupled streptavidin and substrate for
colour development as described previously.v
For standardization of MIP-2 concentrations, MIP-
2 was purified by affinity absorbent as above and
used after determination of protein concentra-
tions by Lowry’s method.a As shown in Fig. 2, a
lineal relation was obtained between concentra-
tion of the purified MIP-2 and absorbance at 490
nm in the concentration range of 20 to 1000 pg/
FIG. 1. Western blotting analysis of purified MIP-2. The 20-h CM
from LPS-stimulated RAW264.7 cells was applied to anti-MIP-2
IgG-conjugated Sepharose column. The lyophilize binding frac-
tion was analysed by SDS-PAGE on 15-25% gradient gel
(Daiichi Pure Chemicals Co. Ltd, Tokyo, Japan) followed by
visualization of protein with dye (lane A). Alternatively, the lyo-
philized CM from LPS-stimulated (lane B) or-unstimulated (lane
C) cells was applied directly to SDS-PAGE as above and then
transferred electrophoretically to a nitrocellulose filter. SDS-PAGE
was carried out in the presence of 2-mercaptoethanol. There-
after, the immunochemical detection of antigenic protein bands
on filter was carried out using biotinylated anti-MIP-2 IgG and
horseradish peroxidase-conjugated streptavidin followed by the
addition of substrate to visualize protein bands. Electrophoresis
calibration kit (Pharmacia, Uppsala, Sweden) was used as MW
standards (31 000, 21 500 and 14400) (lane M).
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FIG. 2. Standardization for concentrations of murine MIP-2 in
ELISA. Purified MIP-2 (see Fig. legend) was diluted with phos-
phate buffered saline and applied to ELISA in which anti-MIP-2
IgG (0.15 mg/ml) and biotinylated anti-MIP-2 IgG (0.05 mg/ml)
were used for capture and second layer antibodies, respectively,
followed by addition of peroxidase-coupled streptavidin and sub-
strate for colour development. The reaction was stopped with 6
N H2SO4 and the optical density at 490 nm was recorded. Tripli-
cate wells were used for each experimental point to calculate
the mean (closed circle) -t- S.E. (thin bar).
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FIG. 3. Time-related production of MIP-2 in LPS-stimulated
RAW264.7 cells. The cells were inoculated into a 96-well micro-
plate at a density of x 105 cells/well. After culture overnight
at 37C, the cells were washed once with serum-free DMEM
and further cultured in the presence of LPS (1 gg/ml). This time
was designated as 0 h. At the indicated times (abscissa), the CM
was collected to detect MIP-2 by ELISA. Triplicate wells were
used for each experimental point to calculate the mean (closed
circle) ___
S.E. (thin bar).
ml, indicating that this ELISA system could detect
quantitatively MIP-2.
When this ELISA system was applied to detect
the time-related production of MIP-2 in LPS-
stimulated RAW264.7 cells, MIP-2 was undetect-
able (less than 20 pg/ml) at 0 h. At 2 h, a low but
recognizable level of MIP-2 (6 ng/ml) was detect-
able, and then this level increased sharply to 32
ng/ml from 4 to 8h and then gradually increased
to 20 h at which the plateau level attained (Fig.
3). In the case of LPS-stimulated P388D1 cells,
which are other murine macrophage-like cells,
MIP-2 was also detected in 20-h CM at a compar-
able level to that in RAW264.7 cells (data not
shown).
Furthermore, because DX is a well-known
inhibitor on certain chemotactic factors such as
human interleukin-8,
9 it was examined whether
this is the case in MIP-2 response. As shown in
Fig. 4, DX inhibited dose-dependently MIP-2 pro-
3 7 duction in a dose range of 10- to 10- M. These
data indicate that MIP-2 production might be
regulated DX-sensitive factors in accordance with
the previous report.
9
In summary, recombinant murine MIP-2 was
expressed as a fusion protein with staphylococcal
protein A to enable easy purification of recombi-
nant MIP-2 and enhance antigenic potential
without the help of a carder protein. This
recombinant MIP-2 was considered to be suffi-
cient for the preparation of antibody from the
aspects of specificity and antigenicity, leading to
establishment of biotin-streptavidin sandwich
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FIG. 4. Inhibitory effect of dexamethasone on the production of
MIP-2 in LPS-stimulated RAW264.7 cells. The cells were cul-
tured in the presence of both LPS and dexamethasone at a dose
range of 0 to 10
-7 M (abscissa). Thereafter, 20-h CM was col-
lected to measure MIP-2 concentrations. Triplicate wells were
used for each experimental point to calculate the mean (thick
bar) 4- S.E. (thin bar). Cell preparation and culture condition
were described in legend for Fig. 3.
ELISA system for murine MIP-2. In some applica-
tions of this ELISA system, time-related MIP-2
production and inhibitory effect of DX on its
production could be detected in a murine mac-
rophage cell line in response to LPS stimulation.
Thus, it is suggested that this assay system
should be useful for the studies of MIP-2
response in various inflammatory models in
mice.
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